Back to search

Sweden· SE-20100706000183

ReFacto AF 3000 IE Pulver och vätska till injektionsvätska, lösning i förfylld spruta

A medicinal product containing moroctocog alfa, registered in Sweden by Pfizer Europe MA EEIG.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedReFacto AF 3000 IE Pulver och vätska …ATC—REGISTER NO.SE-20100706000183PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Moroctocog Alfa
Manufacturer
Pfizer Europe MA EEIG
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20100706000183

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa9ae768-716a-4dad-a74c-25431eb6ad6d
GET /v1/drugs/fa9ae768-716a-4dad-a74c-25431eb6ad6d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20100706000183",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100706000183",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/refacto-af"
}

See everything about moroctocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.